Gga (4160) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 訊聯基因

Gga (4160) reported revenue of NT$47.2 million for Oct 2026, +3.3% year on year and -2.0% from the previous month. Revenue for Jan–Oct 2026 was NT$505.9 million (+5.5% year on year).

Year-on-year revenue growth: 4 months in a row. →

In Oct 2026, it ranked No. 101 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$48 million24/10Nov 2024 NT$47.7 millionDec 2024 NT$59.5 millionJan 2025 NT$41.6 millionFeb 2025 NT$47.1 million25/02Mar 2025 NT$54.6 millionApr 2025 NT$49.1 millionMay 2025 NT$45.3 millionJun 2025 NT$50.7 million25/06Jul 2025 NT$53.7 millionAug 2025 NT$46.5 millionSep 2025 NT$45.2 millionOct 2025 NT$45.7 million25/10Nov 2025 NT$44.5 millionDec 2025 NT$79 millionJan 2026 NT$47.9 millionFeb 2026 NT$36.8 million26/02Mar 2026 NT$64.7 millionApr 2026 NT$52.8 millionMay 2026 NT$47.2 millionJun 2026 NT$50.4 million26/06Jul 2026 NT$58.9 millionAug 2026 NT$51.9 millionSep 2026 NT$48.2 millionOct 2026 NT$47.2 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$47.2 million+3.3%-2.0%
Sep 2026NT$48.2 million+6.5%-7.2%
Aug 2026NT$51.9 million+11.5%-11.8%
Jul 2026NT$58.9 million+9.6%+16.7%
Jun 2026NT$50.4 million-0.5%+7.0%
May 2026NT$47.2 million+4.1%-10.6%
Apr 2026NT$52.8 million+7.5%-18.5%
Mar 2026NT$64.7 million+18.5%+75.9%
Feb 2026NT$36.8 million-21.9%-23.2%
Jan 2026NT$47.9 million+15.0%-39.4%
Dec 2025NT$79 million+32.9%+77.7%
Nov 2025NT$44.5 million-6.8%-2.6%
Oct 2025NT$45.7 million-4.8%+1.0%
Sep 2025NT$45.2 million-9.4%-2.8%
Aug 2025NT$46.5 million-19.7%-13.4%
Jul 2025NT$53.7 million-13.7%+6.0%
Jun 2025NT$50.7 million-5.7%+11.9%
May 2025NT$45.3 million-23.4%-7.7%
Apr 2025NT$49.1 million-13.5%-10.1%
Mar 2025NT$54.6 million-9.5%+15.9%
Feb 2025NT$47.1 million-0.1%+13.1%
Jan 2025NT$41.6 million-29.8%-30.0%
Dec 2024NT$59.5 million+4.6%+24.6%
Nov 2024NT$47.7 million-6.2%-0.5%
Oct 2024NT$48 million-4.0%-3.9%

Jan–Oct 2026 cumulative: NT$505.9 million (+5.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Gga vs PEC / Gga vs Lotus Pharm / Gga vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16